You are here:
In a world first, new Australian research has revealed that genetic profiling can help predict whether an individual will break a bone through osteoporosis. The findings, which arise from Australia’s globally recognised Dubbo Osteoporosis Epidemiology Study, are likely to contribute to clinical decision-making in future, bringing us one step closer to personalised medicine for bone disease.
Garvan’s Kinghorn Centre for Clinical Genomics (KCCG) has achieved a major milestone by sequencing its first 10,000 human genomes since it acquired and installed its Illumina HiSeq X Ten system in 2014.
For the first time, scientists have identified a new network of proteins that are linked to congenital heart disease, which affects 42 babies born every week in Australia.